scholarly journals Developing an E-Business system to improve the downstream pharmaceutical supply chain (A study on the Egyptian market)

2020 ◽  
Author(s):  
Sandra Haddad
Keyword(s):  
Supply Chain ◽  
Distribution Channel ◽  
Pharmaceutical Products ◽  
Inventory Level ◽  
Statistical Tools ◽  
Pharmaceutical Supply Chain ◽  
Qualitative And Quantitative ◽  
Business System ◽  
The Relationship ◽  
Depth Interviews

Pharmaceutical products are considered sensitive products that require a well-managed distribution channel as they impact human lives. The aim of this research is to investigate the applicability of improving the downstream of the pharmaceutical supply chain (distribution channel) in Egypt through developing an E-business system. The study has adopted a deductive approach. Qualitative and quantitative methodologies were followed respectively. Qualitative in-depth interviews were conducted to get a better understanding of the situation in Egypt followed by a structured survey to test and verify the significance and the relation of the extracted variables using statistical tools. This resulted in highlighting significant variables impacting the relationship between pharmaceutical retailers (pharmacies) and consumers and the applicability of introducing an e-business retailing application that improves downstream chain performance by facilitating transactions i.e. easily locating the required medicine, matching consumers and retailers and spotting the inventory level in the distribution channel for better management solutions.

scholarly journals A literature review on multi-echelon inventory management: the case of pharmaceutical supply chain

2018 ◽  
Vol 200 ◽  
pp. 00013 ◽  
Author(s):  
Nouçaiba Sbai ◽  
Abdelaziz Berrado
Keyword(s):  
Supply Chain ◽  
Customer Service ◽  
Inventory Management ◽  
Raw Materials ◽  
Integrated Approach ◽  
Service Level ◽  
Pharmaceutical Products ◽  
Management Problem ◽  
Pharmaceutical Supply Chain ◽  
Customer Service Level

Inventory management remains a key challenge in supply chain management. Many companies recognize the benefits of a good inventory management system. An effective inventory management helps reaching a high customer service level while dealing with demand variability. In a complex supply chain network where inventories are found across the entire system as raw materials or finished products, the need for an integrated approach for managing inventory had become crucial. Modelling the system as a multi-echelon inventory system allows to consider all the factors related to inventory optimization. On the other hand, the high criticality of the pharmaceutical products makes the need for a sophisticated supply chain inventory management essential. The implementation of the multi-echelon inventory management in such supply chains helps keeping the stock of pharmaceutical products available at the different installations. This paper provides an insight into the multi-echelon inventory management problem, especially in the pharmaceutical supply chain. A classification of several multi-echelon inventory systems according to a set of criteria is provided. A synthesis of multiple multi-echelon pharmaceutical supply chain problems is elaborated.

Potential Impact of RFID-Based Tracing Systems on the Integrity of Pharmaceutical Products

2012 ◽  
pp. 1724-1745
Author(s):  
Michele Maffia ◽  
Luca Mainetti ◽  
Luigi Patrono ◽  
Emanuela Urso
Keyword(s):  
Supply Chain ◽  
Radio Frequency ◽  
Radio Frequency Identification ◽  
Electromagnetic Waves ◽  
Peptide Hormone ◽  
Pharmaceutical Products ◽  
Pharmaceutical Supply Chain ◽  
Rf Devices ◽  
And Performance ◽  
Auto Identification

Radio Frequency Identification (RFID) is going to play a crucial role as auto-identification technology in a wide range of applications such as healthcare, logistics, supply chain management, ticketing, et cetera. The use of electromagnetic waves to identify, trace, and track people or goods allows solving many problems related to auto-identification devices based on optical reading (i.e. bar code). Currently, high interest is concentrated on the use of Radio Frequency (RF) solutions in healthcare and pharmaceutical supply chain, in order to improve drugs flow transparency and patients’ safety. Unfortunately, there is a possibility that drug interaction with electromagnetic fields (EMFs) generated by RF devices, such as RFID readers, deteriorate the potency of bioactive compounds. This chapter proposes an experimental multidisciplinary approach to investigate potential alterations induced by EMFs on drug molecular structure and performance. To show the versatility of this approach, some experimental results obtained on two biological pharmaceuticals (peptide hormone-based) are discussed.

Applications of Operations Research in Production and Distribution Management of Pharmaceutical Products

2017 ◽  
pp. 49-77
Author(s):  
Mahsa Yousefi Sarmad ◽  
Mir Saman Pishvaee
Keyword(s):  
Supply Chain ◽  
Pharmaceutical Industry ◽  
Human Life ◽  
Pharmaceutical Products ◽  
Pharmaceutical Supply Chain ◽  
Distribution Management ◽  
Global Industry ◽  
Production And Distribution ◽  
Recent Developments ◽  
Business Entities

Pharmaceutical industry is considered as a global industry because of its effects on the human life. Many researchers used optimization tools to manage the pharmaceutical supply chain (PSC) efficiently. A supply chain may be defined as an integrated process where several business entities work together to produce goods and/or services and deliver them to the end customer. The issue of PSC which includes strategic, tactical and operational decisions, is still a quite hot issue. The intended mission of this chapter is to introduce and discuss the recent developments of procurement, production and distribution management of pharmaceutical products in order to pave the way for the readers who are interested in this area of research. Notably, the focus of the chapter is on quantitative OR-based models which enable the decision makers to appropriately coordinate and manage the whole pharmaceutical industry.

Value Creation in Electronic Supply Chains by Adoption of a Vendor Managed Inventory System

2013 ◽  
pp. 229-240
Author(s):  
Yasanur Kayikci
Keyword(s):  
Supply Chain ◽  
Customer Satisfaction ◽  
Data Exchange ◽  
Decision Makers ◽  
Path Model ◽  
Inventory Level ◽  
Supply Side ◽  
Pls Regression ◽  
Vendor Managed Inventory ◽  
The Relationship

Many strategies have been developed to manage supply chain operations effectively. Vendor Managed Inventory (VMI) system is one of the prevalent strategic tools of the supply side logistics based on the electronic data exchange and business process automation among the suppliers and customers to enhance the competitive advantage. VMI is widely used in different industries including automotive sector. The VMI concept is a continuous replenishment program where suppliers are given access to demand and inventory level of customers and they are fully responsible for managing and replenishing the customer’s stock. VMI’s extension on customer satisfaction cannot be perceived sufficiently by decision-makers who are responsible to develop and invest in the customer-supplier relationship. This paper presents a path model using the method of Partial Least Squares (PLS) regression to give insight to decision-makers to understand effect of the VMI adoption on customer satisfaction. This paper investigates both determinants of relative factors of successful VMI adoption and the relationship in the supply chain with an empirical automotive industry case. The results show that the collaboration and coordination between customer and supplier and infrastructure of the information-sharing are the important dimensions to add value to the supply chain and to enhance customer satisfaction.

Pharmaceutical Supply Chain Management Practices and Organizational Performance

2021 ◽  
Vol 14 (4) ◽  
pp. 20-35
Author(s):  
Musah Osumanu Doumbia ◽  
Iddrisu Awudu ◽  
Mariama Yakubu ◽  
Vinay Gonela
Keyword(s):  
Supply Chain ◽  
Supply Chain Management ◽  
Organizational Performance ◽  
Management Practices ◽  
Partial Least Square ◽  
Least Square ◽  
Pharmaceutical Supply Chain ◽  
Chain Management ◽  
Pharmaceutical Firms ◽  
The Relationship

The purpose of this paper is to use empirical data to examine the effect of supply chain management practices on organizational performance of pharmaceutical firms in a developing country. The conceptual model was based on supply chain management practices. Purposive sampling was used to gather data from cross section of pharmaceutical firms. Partial least square (PLS) structural equation modelling (SEM) approach was used to test the relationship among the constructs. The results show a strong statistically significant positive relationship between supply chain management practice and organizational performance. Supply chain performance was used as a mediating variable, but the result was inconsequential, and it had no effect on the relationship between supply chain management practices and organizational performance.

scholarly journals Securing Pharmaceutical Supply Chain using Blockchain Technology

2021 ◽  
Vol 37 ◽  
pp. 01013
Author(s):  
Vishwesh Lingayat ◽  
Isha Pardikar ◽  
Shubham Yewalekar ◽  
Shyamal Khachane ◽  
Sachin Pande
Keyword(s):  
Supply Chain ◽  
Pharmaceutical Products ◽  
Management Systems ◽  
Smart Contracts ◽  
Counterfeit Drugs ◽  
Supply Chain System ◽  
Pharmaceutical Supply Chain ◽  
Manual Operation ◽  
Blockchain Technology ◽  
Production And Distribution

The production and distribution of counterfeit drugs is an urgent and increasingly critical worldwide issue, especially in pandemics. The imperfect supply chain system in the pharmaceutical industry is one of the reasons for drug counterfeiting. Drugs ownership changes from manufacturers to wholesaler, distributor, and then pharmacist before it reaches the customer thus making it difficult to keep track of it. In this paper, we have compared the existing proposed architectures of blockchain and IoT based supply chain management systems. The system implemented using hyper ledger fabric ensures sharing, storing, transparency, and traceability of data in each link of the supply chain. On the other hand, Ethereum architecture utilized the features of smart contracts to manage the interactions between sender and receiver. Finally, the study mainly focuses on increasing the safety of pharmaceutical products and reducing the manual operation of the supply chain with the most efficient architecture.

scholarly journals The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?

F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 225 ◽  
Author(s):  
Philippe J Guerin ◽  
Sauman Singh-Phulgenda ◽  
Nathalie Strub-Wourgaft
Keyword(s):  
Supply Chain ◽  
Large Scale ◽  
Healthcare Delivery ◽  
Pharmaceutical Products ◽  
Diagnostic Tools ◽  
Scale Production ◽  
Pharmaceutical Supply Chain ◽  
Medical Products ◽  
Medical Response ◽  
The World

While the world is facing the urgency of the COVID-19 pandemic, policymakers must plan for the direct response to the outbreak while minimising its collateral impact. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fundamental to reducing disruption of the healthcare delivery system, which requires constant medicines, diagnostic tools and vaccines for smooth functioning. In this equation, the role of the Indian pharmaceutical industry will not only be critical to meet the domestic need of over 1.3 billion inhabitants but will equally be important for the rest of the world, including wealthy economies. Preventing a significant disruption of the Indian pharmaceutical supply chain during the outbreak and preparing it for large scale production for COVID-19 therapeutic or preventive medical products will not only help India but will assist the global response to this outbreak.

Value Creation in Electronic Supply Chains by Adoption of a Vendor Managed Inventory System

2011 ◽  
Vol 3 (4) ◽  
pp. 17-27
Author(s):  
Yasanur Kayikci
Keyword(s):  
Supply Chain ◽  
Customer Satisfaction ◽  
Automotive Industry ◽  
Data Exchange ◽  
Decision Makers ◽  
Path Model ◽  
Inventory Level ◽  
Vendor Managed Inventory ◽  
The Relationship ◽  
Relative Factors

Many strategies have been developed to manage supply chain operations effectively. Vendor Managed Inventory (VMI) system is one of the prevalent strategic tools of the supply side logistics based on the electronic data exchange and business process automation among the suppliers and customers to enhance the competitive advantage. VMI is widely used in different industries including automotive sector. The VMI concept is a continuous replenishment program where suppliers are given access to demand and inventory level of customers and they are fully responsible for managing and replenishing the customer’s stock. VMI’s extension on customer satisfaction cannot be perceived sufficiently by decision-makers who are responsible to develop and invest in the customer-supplier relationship. This paper presents a path model using the method of Partial Least Squares (PLS) regression to give insight to decision-makers to understand effect of the VMI adoption on customer satisfaction. This paper investigates both determinants of relative factors of successful VMI adoption and the relationship in the supply chain with an empirical automotive industry case. The results show that the collaboration and coordination between customer and supplier and infrastructure of the information-sharing are the important dimensions to add value to the supply chain and to enhance customer satisfaction.

Impact of big data analytics capabilities on supply chain sustainability

2020 ◽  
Vol 17 (1) ◽  
pp. 33-57 ◽  
Author(s):  
Sajjad Shokouhyar ◽  
Mohammad Reza Seddigh ◽  
Farhad Panahifar
Keyword(s):  
Big Data ◽  
Supply Chain ◽  
Data Analytics ◽  
Big Data Analytics ◽  
Sustainable Supply Chain ◽  
Self Assessment ◽  
Pharmaceutical Supply Chain ◽  
Content Type ◽  
Different Dimensions ◽  
The Relationship

Purpose The purpose of this paper is to develop a theoretical model to explain the impact of big data analytics capabilities (BDAC) on company’s supply chain sustainability (CSCS). The secondary objective of the study is to assess the relationship between different dimensions of supply chain sustainability and companies’ BDAC. Design/methodology/approach This research was carried out by conducting a survey among 234 pharmaceutical companies in Iran (a case study of Iran), using a standard questionnaire of BDAC and United Nations (UN) online self-assessment on supply chain sustainability. However, the respond of managers of 188 companies were usable in this research. Smart PLS3 was used to employ partial least squares method to examine the validity and reliability of the measurement and structural model. Findings The results of this study demonstrate that BDAC have a strong impact on both pharmaceutical supply chain sustainability, and the dimensions including vision, engage and internal. It is found that the relationships between BDAC and the other dimensions of supply chain sustainability including expect, scope and goals are not significant but positive. Research limitations/implications Research on the relationship between BDAC and CSCS, especially in the pharmaceutical supply chain, is scanty, and this gap is highlighted in developing countries and the pharmaceutical supply chain that plays a prominent role in public health. This paper discusses several important barriers to forming a sustainable supply chain and strong BDA capabilities. Practical implications This paper could be a guide to managers and consultants who are involved in big data analytics and sustainable development. Since UN urges companies do the online self-assessment, the results of this paper would be attractive and useful for UN global compact specialists. Originality/value No study has directly measured the relation between BDAC and CSCS and different dimensions of CSCS, using a comprehensive survey throughout all pharmaceutical companies in Iran. Moreover, this research assesses the different dimensions of BDA capabilities and supply chain sustainability. This paper represents the facts about situation of sustainability of pharmaceutical supply chain and BDAC in these companies, and discloses several related issues that are serious barriers to forming a sustainable supply chain and strong BDAC. In addition, this paper provided academic support for UN questionnaire about CSCS and used it in the survey.

scholarly journals The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution

2021 ◽  
pp. e1-e5
Author(s):  
Mariana P. Socal ◽  
Joshua M. Sharfstein ◽  
Jeremy A. Greene
Keyword(s):  
Public Health ◽  
Supply Chain ◽  
Acute Stress ◽  
Pharmaceutical Products ◽  
New Drugs ◽  
Pharmaceutical Supply Chain ◽  
The Us ◽  
Production And Distribution ◽  
To Come ◽  
Pharmaceutical Production

The acute stress of the COVID-19 pandemic has laid bare a series of long-term weaknesses in the US public health system, including the fragility of our supply of essential medications.1 The virus produced unprecedented shifts in demand for old as well as new drugs, while simultaneously introducing new uncertainties about the production and distribution of pharmaceutical products. COVID-19–related shortages extended beyond antivirals to include a range of drugs broadly used in intensive care and in general hospital management (Table 1). These shortages point to serious vulnerabilities in the pharmaceutical supply chain that compromise readiness for new waves of the current pandemic and crises that are yet to come. (Am J Public Health. Published online ahead of print January 28, 2021: e1–e5. https://doi.org/10.2105/AJPH.2020.306138 )

Sign in / Sign up

Export Citation Format

Share Document